ADAP EcoR1 Capital LLC sells $3.8M worth of shares
Jul 31, 2025, 4:35 AM
0.00%
What does ADAP do
Adaptimmune Therapeutics Plc, a commercial-stage cell therapy company based in Abingdon, Oxfordshire, focuses on novel T-cell therapies for cancer, including afamitresgene autoleucel and Lete-cel. The company employs 449 people and went public on May 6, 2015.
EcoR1 Capital LLC sold 33,931,740 shares of ADAP on 28 July at $0.11 per share, worth a total of $3.8M. They now own 130,492,680 ADAP shares, or a 21% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
